STAFF REPORTER GUWAHATI: AIIMS Guwahati has welcomed the Centre's initiative to reduce the prices of 137 non-scheduled anti-cancer medicines by up to 70 per cent from November 9, 2026, to make cancer treatment more affordable. The initiative, undertaken by the National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, aims to rationalise trade margins on selected medicines and reduce the financial burden on patients and their families. The medicines include pembrolizumab and durvalumab, used in cancer immunotherapy; osimert...